Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Cash flows from operating activities
Net loss	$ (8,009,882)	$ (6,741,364)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation of property, plant and equipment	572,935	258,088
Amortization of intangible assets	562,887	133,658
Stock-based compensation	918,080	602,003
Equity in loss of investee company	59,412	0
Changes in assets and liabilities
Accounts receivable	(393,667)	56,737
Inventories	(669,990)	(337,621)
Prepaids and other current assets	(111,047)	59,742
Refundable income taxes	7,467	(180,000)
Accounts payable	784,483	68,853
Accrued compensation and benefits	(101,167)	(140,851)
Accrued expenses	(217,668)	35,333
Deferred revenues	108,640	245,587
Net cash used in operating activities	(6,489,517)	(5,939,835)
Cash flows from investing activities
Expenditures for property and equipment	(1,597,097)	(772,892)
Acquisition of business, net of cash acquired	0	(225,922)
Investment in investee company	(1,589,422)	0
Net cash used in investing activities	(3,186,519)	(998,814)
Cash flows from financing activities
Proceeds from bank loans and notes payable	0	1,300,000
Repayments of bank loans and notes payable	(529,273)	(306,744)
Proceeds from issuance of debenture notes payable	0	517,168
Proceeds from issuance of Series A preferred stock	2,197,240	3,030,000
Proceeds from issuance of Common Stock	5,052,401	3,077,582
Common stock issuance costs	(484,983)	0
Deferred offering and financing costs	(93,579)	0
Proceeds from noncontrolling interest	1,546,062	0
Net cash provided by financing activities	7,687,868	7,618,006
Effect of exchange rate changes on cash and cash equivalents	(15,662)	9,545
Net (increase) decrease in cash and cash equivalents	(2,003,830)	688,902
Cash and cash equivalents - beginning of period	2,910,595	1,235,635
Cash and cash equivalents - end of period	906,765	1,924,537
Cash paid for interest	161,954	126,914
Cash received for income tax credit	223,703	0
Supplemental non-cash investing and financing activities:
Conversion of debenture notes payable to Series A preferred stock	0	524,678
Issuance of common stock for discounted notes receivable	2,187,330	3,529,644
Issuance of common stock as consideration for equity issuance costs	0	683,634
Conversion of cash settled RSUs to stock settled RSUs		$ 315,833
Issuance of warrants for purchase of property and equipment	0	11,834